IMP dehydrogenase-linked retinitis pigmentosa

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 839-849

  Hedstrom, Lizbeth ^a,b  

^a BRANDEIS UNIVERSITY   (United States)

^b MS009 ^*  (United States)

Author keywords

Bateman domains; CBS domains; IMPDH1; Leber congenital amaurosis; Moonlighting enzymes

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; GUANINE NUCLEOTIDE; INOSINATE DEHYDROGENASE; INOSINE MONOPHOSPHATE DEHYDROGENASE 1; MESSENGER RNA;

BIOSYNTHESIS; CONFERENCE PAPER; GENE MUTATION; HUMAN; PATHOGENESIS; PHOTORECEPTOR; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINITIS PIGMENTOSA; RNA METABOLISM;

AMINO ACID SEQUENCE; ANIMALS; DNA, SINGLE-STRANDED; HUMANS; IMP DEHYDROGENASE; MOLECULAR SEQUENCE DATA; MUTATION; RETINITIS PIGMENTOSA; RNA, MESSENGER;

EID: 46749097520     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802146486     Document Type: Conference Paper

References (53)

1. Rivolta, C.; Sharon, D.; DeAngelis, M.M.; Dryja, T.P. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum. Mol. Genet. 2002, 11, 1219-1227.
2. Kennan, A.; Aherne, A.; Palfi, A.; Humphries, M.; McKee, A.; et al. Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice. Hum. Mol. Genet. 2002, 11, 547-557.
3. Bowne, S.J.; Sullivan, L.S.; Blanton, S.H.; Cepko, C.L.; Blackshaw, S.; Birch, D.G.; Hughbanks-Wheaton, D.; Heckenlively, J.R.; Daiger, S.P. Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum. Mol. Genet. 2002, 11, 559-568.
4. Wada, Y.; Sandberg, M.A.; McGee, T.L.; Stillberger, M.A.; Berson, E.L.; Dryja, T.P. Screen of the IMPDH1 Gene among Patients with Dominant Retinitis Pigmentosa and Clinical Features Associated with the Most Common Mutation, Asp226Asn. Invest. Ophthalmol. Vis. Sci. 2005, 46, 1735-1741.
5. Hedstrom, L. IMP dehydrogenase: mechanism of action and inhibition. Curr. Med. Chem. 1999, 6, 545-560.
6. Gu, J.J.; Tolin, A.K.; Jain, J.;Huang, H.; Santiago, L.;Mitchell, B.S. Targeted disruption of the inosine 5′-monophosphate dehydrogenase type I gene in mice. Mol. Cell. Biol. 2003, 23, 6702-6712.
7. Jain, J.; Almquist, S.J.; Ford, P.J.; Shlyakhter, D.; Wang, Y.; et al. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. Biochem. Pharmacol. 2004, 67, 767-776.
8. Bowne, S.J.; Liu, Q.; Sullivan, L.S.; Zhu, J.; Spellicy, C.J.; Rickman, C.B.; Pierce, E.A.; Daiger, S.P. Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration? Invest. Ophthalmol. Vis. Sci. 2006, 47, 3754-3765.
9. Grover, S.; Fishman, G.A.; Stone, E.M. A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa. Ophthalmology 2004, 111, 1910-1916.
10. Bowne, S.J.; Sullivan, L.S.; Mortimer, S.E.; Hedstrom, L.; Zhu, J.; et al. Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest. Ophthalmol. Vis. Sci. 2004, 47, 34-42.
11. Aherne, A.; Kennan, A.; Kenna, P.F.; McNally, N.; Lloyd, D.G.; Alberts, I.L.; Kiang, A.S.; Humphries, M.M.; Ayuso, C.; Engel, P.C.; Gu, J.J.; Mitchell, B.S.; Farrar, G.J.; Humphries, P. On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa. Hum. Mol. Genet. 2004, 13, 641-650.
12. Ishikawa, H. Mizoribine and mycophenolate mofetil. Curr. Med. Chem. 1999, 6, 575-597.
13. Colby, T.D.; Vanderveen, K.; Strickler, M.D.; Markham, G.D.; Goldstein, B.M. Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc. Natl. Acad. Sci., USA 1999, 96, 3531-3536.
14. Nimmesgern, E.; Black, J.; Futer, O.; Fulghum, J.R.; Chambers, S.P.; Brummel, C.L.; Raybuck, S.A.; Sintchak, M.D. Biochemical analysis of the modular enzyme inosine monophosphate dehydrogenase. Prot. Expres. Purif. 1999, 17, 282-289.
15. Gan, L.; Petsko, G.A.; Hedstrom, L. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5′-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis. Biochemistry 2002, 41, 13309-13317.
16. Mortimer, S.E.; Hedstrom, L. Autosomal dominant retinitis pigmentosa mutations in inosine 5′-monophosphate dehydrogenase type I disrupt nucleic acid binding. Biochem. J. 2005, 390, 41-47.
17. Kemp, B.E. Bateman domains and adenosine derivatives form a binding contract. J. Clin. Invest. 2005, 113, 182-184.
18. Ignoul, S.; Eggermont, J. CBS domains: structure, function, and pathology in human proteins. Am. J. Physiol. Cell Physiol. 2005, 289, C1369-C1378.
19. Scott, J.W.; Hawley, S.A.; Green, K.A.; Anis, M.; Stewart, G.; Scullion, G.A.; Norman, D.G.; Hardie, D.G. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 2004, 113, 274-284.
20. Carr, S.F.; Papp, E.; Wu, J.C.; Natsumeda, Y. Characterization of human type I and type II IMP dehydrogenases. J. Biol. Chem. 1993, 268, 27286-27290.
21. Holmes, E.; Pehlke, D.; Kelley, W. Human IMP dehydrogenase. Kinetics and regulatory properties. Biochim. Biophys. Acta 1974, 364, 209-217.
22. McLean, J.E.; Hamaguchi, N.; Belenky, P.; Mortimer, S.E.; Stanton, M.; Hedstrom, L. Inosine 5′-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo. Biochem. J. 2004, 379, 243-251.
23. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
24. Keene, J.D.; Tenenbaum, S.A. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 2004, 9, 1161-1167.
25. Tenenbaum, S.A.; Carson, C.C.; Lager, P.J.; Keene, J.D. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. USA 2000, 97, 14085-14090.
26. Wang, Y.; Liu, C.L.; Storey, J.D.; Tibshirani, R.J.; Herschlag, D.; Brown, P.O. Precision and functional specificity in mRNA decay. Proc. Natl. Acad. Sci. USA 2002, 99, 5860-5865.
27. Eystathioy, T.; Chan, E.K.; Tenenbaum, S.A.; Keene, J.D.; Griffith, K.; Fritzler, M.J. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell 2002, 13, 1338-1351.
28. Ho, Y.; Gruhler, A.; Hellbut, A.; Bader, G.D.; Moore, L.; Adams, S.-L.; Millar, A.; Taylor, P.; Bennett, K.; Boutliller, K.; Yang, L.; Wolting, C.; Donaldson, I.; Scchandorff, S.; Shewnarane, J.; Vo, M.; Taggart, J.; Goudreault, M.; Muskat, B.; Alfarano, C.; Dewar, D.; Lin, Z.; Michalickova, K.; Willems, A.R.; Sasl, H.; Nielsen, P.A.; Rasmussen, K.J.; Andersen, J.R.; Johansen, L.E.; Hansens, L.K.; Jespersen, H.; Podtelejnikov, A.; Neilsen, E.; Crawford, J.; Poulsens, V.; Sorensen, B.D.; Matthiesen, J.; Hendrickson, R.C.; Gleeson, F.; Pawson, T.; Moran, M.F.; Durocher, D.; Mann, M.; Hogue, C.W.V.; Figeys, D.; Tyers, M. Systematic identification of protein complexes in Sacccharomyces cerevisiae by mass spectrometry. Nature 2002, 415, 180-183.
29. Shepard, K.A.; Gerber, A.P.; Jambhekar, A.; Takizawa, P.A.; Brown, P.O.; et al. Widespread cytoplasmic mRNA transport in yeast: identification of 22 bud-localized transcripts using DNA microarray analysis. Proc. Natl. Acad. Sci. USA 2003, 100, 11429-11434.
30. Gebauer, F.; Hentze, M.W. Molecular mechanisms of translational control. Nat. Rev. Mol. Cell Biol. 2004, 5, 827-835.
31. Holcik, M.; Sonenberg, N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 2005, 6, 318-327.
32. Sung, C.H.; Tai, A.W. Rhodopsin trafficking and its role in retinal dystrophies. Int. Rev. Cytol. 2000, 195, 215-267.
33. Gunawardena, S.; Goldstein, L.S. Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. J. Neurobiol. 2004, 58, 258-271.
34. St. Johnston, D. Moving messages: the intracellular localization of mRNAs. Nat. Rev. Mol. Cell. Biol. 2005, 6, 363-375.
35. Bashirullah, A.; Cooperstock, R.L.; Lipshitz, H.D. RNA localization in development. Annu. Rev. Biochem. 1998, 67, 335-394.
36. Tekotte, H.; Davis, I. Intracellular mRNA localization: motors move messages. Trends Genet. 2002, 18, 636-642.
37. Lipshitz, H.D.; Smibert, C.A. Mechanisms of RNA localization and translational regulation. Curr. Opin. Genet. Dev. 2000, 10, 476-488.
38. Liu, Q.; Cukras, C.; Bowne, S.J.; Zhu, J.; Sullivan, L.S.; Daiger, S.P.; Pierce, E.A. A Potential Interaction Between the RP1 and IMPDH1 Proteins. ARVO 2005 (Abstr. 1710).
39. Liu, Q.; Zhou, J.; Daiger, S.P.; Farber, D.B.; Heckenlively, J.R.; Smith, J.E.; Sullivan, L.S.; Zuo, J.; Milam, A.H.; Pierce, E.A. Identification and subcellular localization of the RP1 protein in human and mouse photoreceptors. Invest. Ophthalmol. Vis. Sci. 2002, 43, 22-32.
40. Gao, J.; Cheon, K.; Nusinowitz, S.; Liu, Q.; Bei, D.; Atkins, K.; Azimi, A.; Daiger, S.P.; Farber, D.B.; Heckenlively, J.R.; Pierce, E.A.; Sullivan, L.S.; Zuo, J. Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene. Proc. Natl. Acad. Sci. USA 2002, 99, 5698-5703.
41. Wilusz, C.J.; Wilusz, J. Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet. 2004, 20, 491-497.
42. Meyer, S.; Temme, C.; Wahle, E. Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit. Rev. Biochem. Mol. Biol. 2004, 39, 197-216.
43. Tan, E.; Wang, Q.; Quiambao, A.B.; Xu, X.; Qtaishat, N.M.; Peachey, N.S.; Lem, J.; Fliesler, S.J.; Pepperberg, D.R.; Naash, M.I.; Al-Ubaidi, M.R. The relationship between opsin overexpression and photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42, 589-600.
44. Olsson, J.E.; Gordon, J.W.; Pawlyk, B.S.; Roof, D.; Hayes, A.; Molday, R.S.; Mukai, S.; Cowley, G.S.; Berson, E.L.; Dryja, T.P. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 1992, 9, 815-830.
45. Nour, M.; Ding, X.Q.; Stricker, H.; Fliesler, S.J.; Naash, M.I. Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest. Ophthalmol. Vis. Sci. 2004, 45, 2514-2521.
46. Cheng, T.; Peachey, N.S.; Li, S.; Goto, Y.; Cao, Y.; Naash, M.I. The effect of peripherin/rds haploinsufficiency on rod and cone photoreceptors. J. Neurosci. 1997, 17, 8118-8128.
47. Ingelfinger, D.; Arndt-Jovin, D.J.; Luhrmann, R.; Achsel, T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 2002, 8, 1489-1501.
48. van Dijk, E.; Cougot, N.; Meyer, S.; Babajko, S.; Wahle, E.; Seraphin, B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 2002, 21, 6915-6924.
49. Sheth, U.; Parker, R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003, 300, 805-808.
50. Cougot, N.; Babajko, S.; Seraphin, B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 2004, 165, 31-40.
51. Bashirullah, A.; Cooperstock, R.L.Lipshitz, H.D. (2001) Spatial and temporal control of RNA stability. Proc. Natl. Acad. Sci. USA 2001, 98, 7025-7028.
52. Zhang, R.-G.; Evans, G.; Rotella, F.J.; Westbrook, E.M.; Beno, D.; Huberman, E.; Joachimiak, A.; Collart, F.R. Characteristics and crystal structure of bacterial inosine-5′-monophosphate dehydrogenase. Biochemistry 1999, 38, 4691-4700.
53. Meng, E.C.; Ferrin, T.E. UCSF Chimera- a visualization system for exploratory research and analysis. J. Comp. Chem. 2004, 25, 1605-1612.